MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202527106583 A) filed by Zydus Lifesciences Limited on November 04, 2025, for Pharmaceutical Composition For The Treatment Of Radiation Induced Toxicity.
Inventors include Jain, Mukul Pctin Application No; Joharapurkar, Amit; Patel, Vishal; Kothari, Jay Wo Publication No; Kannan, Muthaiyyan Essakimuthu; Laddha, Ritu Application Number; Ukawala, Mukesh; and Sahu, Sunil.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to parenteral pharmaceutical compositions of suitable Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, particularly to Desidustat or suitable pharmaceutically acceptable salts thereof. The invention also relates to processes for preparing such compositions. The present invention also relates to the development of therapeutic compound for the treatment of radiation induced toxicity. Specifically, present invention relates to use of Desidustat or its pharmaceutically acceptable salt or oral and parenteral pharmaceutical composition thereof for the treatment of radiation induced toxicity.
Disclaimer: Curated by HT Syndication.
